Answers are grounded in this paper and cite their sources.
Purpose Supercritical carbon dioxide (SCCO 2 ) processing may preserve the structural properties of cadaveric fascia while avoiding donor-site morbidity associated with autologous fascial harvest. Clinical outcomes of SCCO₂-processed fascia lata have not previously been reported in continence surgery. Our study evaluated efficacy and safety outcomes following SCCO₂-processed cadaveric fascia lata pubovaginal sling (PVS) surgery for female stress urinary incontinence (SUI). Methods This prospective, single-centre, single-surgeon observational cohort included 24 consecutive women undergoing SCCO₂-processed fascia lata PVS surgery. Patient-reported outcomes were assessed using the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI SF) and Patient Global Impression of Improvement (PGI-I) at 6 weeks, 6 months and 12 months. Primary outcome was change in ICIQ-UI SF and PGI-I from baseline to 12 months. Perioperative and graft-related complications were recorded prospectively. Results Baseline median ICIQ-UI SF was 15.5 (IQR 14–16). Twelve-month outcome data were available for 18 participants with a median ICIQ-UI SF of 4 (IQR 0–6), and a median within-participant improvement of 11 points (IQR 9–15; p<0.001). Thirteen (72.2%) reported being “very much better” on PGI-I; subjective SUI cure / improvement were reported by 17/18 (94.4%). Graft exposure occurred in 3/24 (12.5%). Conclusion SCCO₂-processed cadaveric fascia lata PVS was associated with substantial improvement in patient-reported continence outcomes at 12 months. These preliminary findings support further prospective evaluation with larger comparative cohorts and longer follow-up.
No takes yet. Share an insight, caveat, or question.
Kyaw et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: